| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 227,9 k € | -24.5% | 301,7 k € | -22.7% | 390,5 k € | -2.1% | 398,8 k € | +156.0% | 155,8 k € | -29.3% | 220,3 k € | -5.2% | 232,3 k € | +25.9% | 184,5 k € | -23.0% | 239,6 k € | +19.1% | 201,2 k € | -6.0% | 214,1 k € | +8.7% | 197,0 k € | +17.1% | 168,3 k € | +4.1% | 161,7 k € | +3.4% | 156,4 k € | -2.2% | 159,9 k € | -2.7% | 164,4 k € | -57.1% | 383,5 k € | +7.2% | 357,8 k € | |
| EBITDA | 217,8 k € | -25.9% | 294,0 k € | -23.0% | 382,0 k € | -2.5% | 391,9 k € | +162.0% | 149,6 k € | -30.7% | 215,8 k € | -3.2% | 222,9 k € | +27.4% | 174,9 k € | -23.9% | 229,8 k € | +18.7% | 193,6 k € | -6.4% | 206,9 k € | +8.2% | 191,2 k € | +17.3% | 163,1 k € | +4.2% | 156,6 k € | +3.5% | 151,3 k € | -2.3% | 154,9 k € | -3.3% | 160,2 k € | -57.7% | 379,0 k € | +7.2% | 353,5 k € | |
| Operating profit | 162,0 k € | -32.4% | 239,7 k € | -27.2% | 329,2 k € | +0.9% | 326,5 k € | +247.2% | 94,0 k € | -40.0% | 156,8 k € | +41.9% | 110,5 k € | +71.4% | 64,4 k € | -30.4% | 92,6 k € | +50.3% | 61,6 k € | +21.1% | 50,9 k € | -25.1% | 67,9 k € | +76.9% | 38,4 k € | +0.5% | 38,2 k € | +42.1% | 26,9 k € | +9.4% | 24,6 k € | +61.6% | 15,2 k € | -91.0% | 168,8 k € | -17.4% | 204,4 k € | |
| Profit/loss | 125,3 k € | -33.7% | 188,9 k € | -8.4% | 206,3 k € | -7.2% | 222,3 k € | +188.3% | 77,1 k € | -44.9% | 139,8 k € | +29.2% | 108,2 k € | +147.1% | 43,8 k € | -13.8% | 50,8 k € | +388.6% | -17,6 k € | -351.7% | 7,0 k € | -78.0% | 31,8 k € | +758.7% | 3,7 k € | +236.3% | -2,7 k € | +85.6% | -18,8 k € | +10.3% | -21,0 k € | +57.5% | -49,3 k € | -157.6% | 85,6 k € | -27.9% | 118,7 k € | |
| Equity | 1,8 M € | -4.0% | 1,9 M € | +7.9% | 1,7 M € | +11.6% | 1,6 M € | +12.3% | 1,4 M € | +5.8% | 1,3 M € | +9.5% | 1,2 M € | +9.9% | 1,1 M € | +4.2% | 1,1 M € | +5.1% | 1,0 M € | -1.7% | 1,0 M € | +0.7% | 1,0 M € | +3.2% | 979,7 k € | +0.4% | 976,0 k € | -0.3% | 978,7 k € | -1.9% | 997,5 k € | -2.1% | 1,0 M € | -4.6% | 1,1 M € | +8.7% | 982,2 k € | |
| Total assets | 1,9 M € | -4.6% | 2,0 M € | +3.1% | 1,9 M € | +4.3% | 1,8 M € | +6.6% | 1,7 M € | -4.4% | 1,8 M € | +1.7% | 1,8 M € | -2.0% | 1,8 M € | -2.2% | 1,8 M € | +15.4% | 1,6 M € | -6.8% | 1,7 M € | +2.7% | 1,7 M € | +6.7% | 1,6 M € | -4.4% | 1,6 M € | -3.1% | 1,7 M € | -4.3% | 1,8 M € | -2.1% | 1,8 M € | -9.9% | 2,0 M € | +4.7% | 1,9 M € | |
| Cash | 62,6 k € | +3.7% | 60,4 k € | -33.9% | 91,2 k € | +38.9% | 65,7 k € | +89.6% | 34,6 k € | +435.7% | 6,5 k € | -84.4% | 41,6 k € | -49.6% | 82,5 k € | +119.6% | 37,5 k € | +91.1% | 19,7 k € | -59.0% | 47,9 k € | -77.0% | 208,5 k € | +121.2% | 94,3 k € | -59.5% | 232,7 k € | +77.3% | 131,2 k € | +23.3% | 106,4 k € | -62.2% | 281,8 k € | -0.6% | 283,4 k € | -32.5% | 419,8 k € | |
| Debts | 59,8 k € | -19.8% | 74,6 k € | -51.8% | 154,7 k € | -40.1% | 258,2 k € | -18.9% | 318,2 k € | -33.0% | 474,8 k € | -15.1% | 559,5 k € | -20.4% | 703,2 k € | -10.7% | 787,7 k € | +32.8% | 592,9 k € | -14.1% | 690,2 k € | +5.6% | 653,6 k € | +12.4% | 581,3 k € | -11.4% | 656,4 k € | -7.1% | 706,3 k € | -7.5% | 763,7 k € | -2.2% | 780,5 k € | -16.0% | 929,4 k € | +0.3% | 926,2 k € | |
Private limited company · Alveringem · incorporated on 08/05/1998
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DRS LAGROU-VERHAEGHE is a Private limited company incorporated in 1998. Its main activity is: Specialist medical practice activities. Its registered office is in Alveringem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette